Journal article

Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report

F Kapczinski, PVS Magalhaes, V Balanza-Martinez, VV Dias, S Frangou, CS Gama, A Gonzalez-Pinto, I Grande, K Ha, M Kauer-Sant'Anna, M Kunz, R Kupka, M Leboyer, C Lopez-Jaramillo, RM Post, JK Rybakowski, J Scott, S Strejilevitch, M Tohen, G Vazquez Show all

Acta Psychiatrica Scandinavica | WILEY | Published : 2014

University of Melbourne Researchers

Grants


Funding Acknowledgements

Prof. Kapczinski has received grants/research support from AstraZeneca, Eli Lilly, Janssen-Cilag, Servier, CNPq, CAPES, NARSAD and Stanley Medical Research Institute; has been a member of the board of speakers for AstraZeneca, Eli Lilly, Janssen and Servier; and has served as a consultant for Servier. Vasco Videira Dias is consultant for Angelini Pharmaceutical, Portugal, and has received educational grants from Lundbeck, Sanofi-Aventis, AstraZeneca and Bristol-Myers Squibb. Dr. Vazquez has served as consultant or speaker for Abbott, AstraZeneca, Gador, Glaxo-SmithKline, Ivax/Teva, Eli Lilly, Lundbeck, Pfizer, Raffo, Servier and Novartis within the last 3 years. Dr. I. Grande has received a research grant Rio Hortega Contract (CM12/00062), Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain, and has served as a speaker for AstraZeneca. Dr Balanza-Martinez has received grants and served as consultant, advisor or CME speaker during the last 3 years for the following entities: Angelini, AstraZeneca, Bristol-Myers-Squibb, Janssen, Juste, Lilly, Otsuka, the Spanish Ministry of Science and Innovation (CIBERSAM), and 'Fundacion Alicia Koplowitz '. Sergio A. Strejilevich has served as consultant or speaker for Glaxo Smith Kline, AstraZeneca, Lilly, Abbott and has received educational grants from Servier. Jan Scott has received funding toward the costs of attending national and international conferences, or fees for talks on psychosocial aspects of bipolar disorders, or advisory board fees from Astra Zeneca, BMS-Otsuka, Eli Lilly, GSK, Jansen-Cilag, Lundbeck, Sanofi-Aventis and Servier. Dr. Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: Adamed, Alexza, Almirall, AstraZeneca, Bial, Bristol-Myers Squibb, Elan, Eli Lilly, Ferrer, Forest Research Institute, Gedeon Richter, Glaxo-Smith-Kline, Janssen-Cilag, Jazz, Johnson & Johnson, Lundbeck, Merck, Novartis, Organon, Otsuka, Pfizer, Pierre-Fabre, Qualigen, Roche, Sanofi-Aventis, Servier, Shering-Plough, Shire, Solvay, Sunovion, Takeda, Teva, the Spanish Ministry of Science and Innovation (CIBERSAM), the Seventh European Framework Programme (ENBREC), the Stanley Medical Research Institute, United Biosource Corporation, and Wyeth. Clarissa S Gama has served as consultant or speaker for Actelion Pharmaceuticals, Eli Lilly, Lundbeck and Roche. Michael Berk has received grant/research support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, MBF, NHMRC, Beyond Blue, Rotary Health, Geelong Medical Research Foundation, Bristol-Myers Squibb, Eli Lilly, Glaxo Smith-Kline, Meat and Livestock Board, Organon, Novartis, Mayne Pharma, Servier and Woolworths and has been a speaker for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo Smith-Kline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck Merck and Servier. Dr. Yatham is on speaker/advisory boards for or has received research grants from: AstraZeneca, Bristol-Myers Squibb, CIHR, CANMAT, Eli Lilly, GlaxoSmithKline, Janssen, Lundbeck, the Michael Smith Foundation for Health Research, Pfizer, Servier, Sunovion and the Stanley Foundation. Janusz K.Rybakowski has acted over the past 2 years as a consultant or as a speaker for the following companies: Bristol- Myers-Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, Sanofi-Aventis and Servier. Marion Leboyer served as a speaker to Servier, AstraZeneca and received research grants from Sanofi and Roche. Prof. Kauer-Sant'Anna has received research grants from NARSAD, SMRI, Universal-CNPq, CNPq/INCT-TM, FIPE-HCPA, and is on the speaker board for Eli-Lilly. Carlos Lopez-Jaramillo has received Grant/Research Support from the Colciencias, Universidad de Antioquia, NIMH, and Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo SmithKline, Novartis, AstraZeneca, Bristol- Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Pfizer, Sanofi Synthelabo, and served as a consultant/speaker to Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Pfizer and Servier. Dr. Gonzalez- Pinto has received grants and served as consultant, advisor or CME speaker for the following entities: AstraZeneca, Bristol-Myers Squibb, Cephalon, Eli Lilly, Janssen-Cilag, Lundbeck, Merck, Otsuka, Pfizer, Sanofi-Aventis, Servier, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Governement, the Stanley Medical Research Institute, and Wyeth. Ralph Kupka received unrestricted research grants from AstraZeneca and served as a speaker for AstraZeneca, Eli-Lilly, Lundbeck and Bristol-Myers-Squibb.